SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

535469

INE0LA901015

12.7840006

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JFLLIFE

7.71

37.12

EPS(TTM)

Face Value()

Div & Yield %

1.46

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	82.04	46.55	42.83	33.59	32.77	30.17
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	82.04	46.55	42.83	33.59	32.77	30.17
Other Income	0.01	0.51	1.64	0.89	0.09	0.03
Stock Adjustments	0.66	-0.62	-2.45	4.69	-0.15	0.27
Total Income	82.71	46.44	42.02	39.17	32.71	30.47
EXPENDITURE :
Raw Materials	66.77	39.33	33.26	30.49	28.76	26.72
Power & Fuel Cost	0.48	0.48	0.34	0.30	0.19	0.30
Employee Cost	1.01	0.91	1.83	1.43	0.98	1.25
Other Manufacturing Expenses	0.22	0.15	0.29	0.08	0.02	0.08
Selling & Administrative Expenses	5.95	0.44	0.63	0.56	0.29	0.16
Miscellaneous Expenses	0.08	0.04	0.10	0.06	0.22	0.06
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	74.50	41.34	36.45	32.92	30.46	28.57
Operating Profit	8.21	5.10	5.56	6.25	2.25	1.89
Interest	1.08	0.86	1.42	2.08	1.23	1.16
Gross Profit	7.13	4.24	4.14	4.17	1.02	0.73
Depreciation	0.99	0.44	0.43	0.37	0.28	0.24
Profit Before Tax	6.14	3.80	3.71	3.80	0.74	0.49
Tax	1.53	0.80	0.91	0.95	0.16	0.12
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.45	-0.30	0.00	0.04	0.04	0.02
Reported Net Profit	4.16	3.30	2.81	2.81	0.54	0.36
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	4.16	3.30	2.81	2.81	0.54	0.36
Adjustment below Net Profit	-6.35	0.01	0.00	-1.86	0.00	0.00
P & L Balance brought forward	8.93	5.62	2.81	1.86	1.27	0.91
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.28	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	6.46	8.93	5.62	2.81	1.81	1.27
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	2.50	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.25	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.26	3.00	2.55	3.50	10.91	8.52
Earnings Per Share(Adj)-Unit Curr	1.26	1.00	0.85	3.50	10.91	8.52
Book Value-Unit Curr	11.96	32.35	29.34	14.08	138.28	127.11
Book Value(Adj)-Unit Curr	11.96	10.79	9.78	14.08	138.28	127.11

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)